1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Earnings

Amyris Moving 30 Molecules Through R&D Pipeline, Streamlining Consumer Portfolio

 
• By Eileen Francis

Amyris, Inc. is developing 30 molecules using its bio-fermentation technology, negotiating a bio-manufacturing joint venture that could yield $50m-$100m in proceeds, and simplifying its Consumer portfolio to unlock value. Cost containment and liquidity will continue to be key priorities for the synthetic biotech firm while it targets up to 100% revenue growth in fiscal 2023.

Test Tube Plants
• Source: Shutterstock

Amyris, Inc. expects to grow revenues and unlock value in its Consumer and Technology Access businesses through the commercialization of new biotech molecules and the sale of non-core assets, among other initiatives.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

Reducing Complexity Helps Weleda Break Sales Record

 
• By Tom Gallen

Swiss firm reports highest revenues in its history as restructure pays off for its pharma and cosmetics businesses in 2024.

Coty: Fragrance Demand Strong, But Retail Dynamics Weigh On 2025 Outlook

 
• By Eileen Francis

Coty Inc. reports fiscal second quarter sales slipped 3% on a reported basis to $1.67bn, reflecting further slowing of the mass beauty market, particularly color cosmetics.

US ‘Land Of Opportunity’ For Beauty On Population Trends, Consumption – L’Oréal

 
• By Eileen Francis

L’Oréal Groupe expects total sales in 2025 to beat 4%-4.5% growth anticipated for the overall beauty market, with US population growth, planned innovations boding well across its beauty businesses.

P&G North America: ‘Whole Body’ Deodorants Freshen Beauty Segment As Skin Care Slides

 
• By Eileen Francis

Cincinnati-based P&G reports its antiperspirants/deodorants business is a ‘pocket of strength,’ growing 11% in the US in the fiscal second quarter and helping lift overall beauty sales as skin care stumbles.

More from Business

NAD/CARU Review Of Beauty Firm’s Social Media Posts Shows Impact Of ‘Sephora Kids’ Trend

 
• By Eileen Francis

BBB National Programs’ NAD and CARU divisions jointly reviewed the social media posts of New York firm Bubble Beauty, finding the company could support claims of safety, but not efficacy, of its skin care products for children under 13.

L’Oréal Sells ‘Pioneering’ Carol’s Daughter Hair Brand After 20-Year Ownership

 
• By Eileen Francis

L’Oréal USA has sold multi-cultural hair care brand Carol’s Daughter to an independent beauty entrepreneur with a ‘proven track record’ of acquiring and growing beauty brands, while it remains under the leadership of its founder and new President, Lisa Price.

Target Beauty’s In-Store Presentation, Digital Support Nearly Double Division’s Sales Since 2019

 
• By Eileen Francis

Target’s Beauty division was its strongest business unit in fiscal 2024, nearly doubling in six years to reach $13.2bn on strong in-store presentation and digital support, the retailer says.